Disclosed venture financings sunk to their lowest number in six years, but larger round sizes kept the total raised stable
Data Byte
Discovery & Translation
BioCentury identifies 44 new targets presented at meeting
BioCentury’s roundup of translational innovations
Finance
Plus public offerings for Biohaven and TScan, and PIPEs for Cullinan and Zura
Management Tracks
Plus: Baptista joins SmartCella and updates from LifeArc and Gain
BioCentury ISSN 1097-7201